SastiSehat
?

Medically ReviewedUpdated 4/8/2026

Generic:Upadacitinib

1 INDICATIONS AND USAGE RINVOQ/RINVOQ LQ is a Janus kinase (JAK) inhibitor. RINVOQ is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or more TNF blockers. ( 1 ) Limitations of Use RINVOQ is not recommended for use in combination with other JAK inhibitors, biologic DMARDs, or with potent immunosuppressants such as azathioprine and cyclosporine. ( 1 ) RINVOQ/RINVOQ LQ is indicated for the treatment of adults and pediatric patients 2 years of age and older with active psoriatic arthritis who have had an inadequate response or intolerance to one or more TNF blockers. (
Best PriceRs. 6000
Availability In Stock

Important Medical Notice & Prescription Requirement

is a medical product. If this is a prescription-only medicine, it must only be used under strict medical supervision and with a valid prescription. Do not self-medicate based on information provided here.

The content on SastiSehat is for informational purposes only and is not a substitute for professional medical advice. Always consult a licensed doctor or pharmacist before starting any new medication or treatment.

Clinically Equivalent Alternatives

These medicines contain the same active ingredient,and are medically equivalent to Rinvok 15mg Tablets 10s.

Uses & Indications

  • 1 INDICATIONS AND USAGE RINVOQ/RINVOQ LQ is a Janus kinase (JAK) inhibitor. RINVOQ is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or more TNF blockers. (
  • 1 ) Limitations of Use RINVOQ is not recommended for use in combination with other JAK inhibitors, biologic DMARDs, or with potent immunosuppressants such as azathioprine and cyclosporine. (
  • 1 ) RINVOQ/RINVOQ LQ is indicated for the treatment of adults and pediatric patients 2 years of age and older with active psoriatic arthritis who have had an inadequate response or intolerance to one or more TNF blockers. (

Side Effects

  • 6 ADVERSE REACTIONS The following clinically significant adverse reactions are described elsewhere in the labeling: Serious Infections [see Warnings and Precautions (
  • 1 )] Mortality [see Warnings and Precautions (
  • 2 )] Malignancy and Lymphoproliferative Disorders [see Warnings and Precautions (

Safety Warnings

  • WARNING: SERIOUS INFECTIONS, MORTALITY, MALIGNANCY, MAJOR ADVERSE CARDIOVASCULAR EVENTS, and THROMBOSIS SERIOUS INFECTIONS Patients treated with RINVOQ /RINVOQ LQ are at increased risk for developing serious infections that may lead to hospitalization or death [see Warnings and Precautions (
  • 1 ), Adverse Reactions (

Common Questions about

What is used for?

is a medication primarily used to treat conditions associated with its active ingredients. It belongs to the pharmaceutical class of medicines.

What are the side effects of ?

Common side effects of may include 6 ADVERSE REACTIONS The following clinically significant adverse reactions are described elsewhere in the labeling: Serious Infections [see Warnings and Precautions (. If you experience severe reactions, consult your doctor immediately.

What is the price of in Pakistan?

The latest price for in Pakistan is Rs. 6000. Prices may vary by pharmacy and location (Lahore, Karachi, Islamabad).

Dosage Information

2 DOSAGE AND ADMINISTRATION RINVOQ LQ oral solution is not substitutable with RINVOQ extended-release tablets ( 2.